chemoprevention trials

Related by string. * Chemoprevention : researching PI3K chemoprevention . lung cancer chemoprevention . cancer chemoprevention . chemoprevention / trialed . trialing . Trials . TRIAL . Trial . TRIALS . trialer : Phase III clinical trials . Week Premium Trial . Phase III trials . placebo controlled clinical trials . randomized controlled trial . randomized controlled trials * *

Related by context. Frequent words. (Click for all words.) 63 molecular biomarkers 62 therapeutic regimens 62 liver transplant recipients 61 subgroup analyzes 61 colorectal cancer CRC 61 figitumumab 60 lymph node dissection 60 liver biopsies 60 Observational studies 60 mycophenolate mofetil 60 chemoradiotherapy 60 tanespimycin 60 multivariate analyzes 59 Neuradiab 59 neoadjuvant therapy 59 retrospective cohort study 59 FDG PET 59 forodesine 59 haematological 59 prospectively defined 59 NSABP 59 systemic toxicity 59 adjuvant therapy 59 prognostic significance 58 elotuzumab 58 HSCT 58 immunohistochemical 58 androgen deprivation 58 warfarin therapy 58 malignant pleural mesothelioma 58 immunosuppressive agents 58 histopathological 58 calcineurin inhibitors 58 neoadjuvant chemotherapy 58 cytotoxic chemotherapy 58 surrogate markers 58 lipid abnormalities 58 colorectal carcinoma 58 breast carcinoma 58 tibolone 58 pharmacoeconomic 58 SWOG 57 generalizability 57 TRISENOX 57 atacicept 57 Azedra 57 optimal dosing 57 epidemiologic studies 57 pharmacodynamic effects 57 lymphadenectomy 57 atherothrombosis 57 carotid artery stenting 57 paroxysmal nocturnal hemoglobinuria 57 malignant transformation 57 NHANES III 57 placebo controlled clinical 57 concomitant medications 57 pharmacokinetic PK 57 colorectal adenomas 57 axitinib 57 RRMS patients 57 tigecycline 57 neuropsychiatric symptoms 57 histopathologic 57 computed tomography CT scans 57 neoplastic 57 nonmelanoma skin cancer 57 endometrial cancers 57 prognostic marker 57 thromboprophylaxis 56 goserelin 56 myeloproliferative disorders 56 allogeneic stem cell 56 RTOG 56 glitazones 56 antibiotic prophylaxis 56 nonrandomized 56 HER2 positive metastatic breast 56 hyperglycaemia 56 carcinoid tumors 56 adjuvant radiation 56 QTc prolongation 56 cirrhotic patients 56 genotoxicity 56 EORTC 56 ERCP 56 neoadjuvant 56 bisphosphonate therapy 56 biochemical recurrence 56 transurethral resection 56 mRCC 56 imetelstat 56 bevacizumab Avastin 56 MR spectroscopy 56 CR# vcMMAE 56 epithelial ovarian cancer 56 SABCS 56 malignant lesions 56 iclaprim 56 vitro experiments 56 superficial bladder cancer

Back to home page